In Collierville, Tennessee, pharmacist Dr. Ryan Wooden demonstrates how a 3D printer produces testosterone lozenges at his compounding pharmacy. Soon, patients may also be able to purchase peptides directly from such pharmacies.
Peptides—short chains of amino acids—have surged in popularity online, promoted for benefits ranging from muscle growth to anti-aging. While some peptide-based drugs like insulin and GLP-1 medications (Ozempic, Wegovy) are FDA-approved, many products circulating on social media are experimental and labeled “for research use only.”
Experts warn of risks with these unregulated versions. Dr. Wooden has seen contaminated vials brought in by customers and cited cases where patients received dangerous substances instead of weight-loss treatments. Safety concerns such as sterility, dosing, and quality control remain major issues.
At a recent FDA advisory meeting, six peptides—including BPC-157, TB-500, and Epitalon—were recommended for compounding due to potential healing properties, though human clinical data is still limited. Dr. Richard Bloomer of the University of Memphis emphasized the need for more rigorous trials before widespread use.
If the FDA finalizes approval, compounding pharmacies would be required to test and verify peptide quality before dispensing. Wooden stressed that consumer safety will be the top priority, while Bloomer advised patients to consult providers and ask critical questions about efficacy, safety, and cost.
For now, the timeline for FDA action remains uncertain, but state pharmacy boards are expected to begin discussions on regulating peptide compounding.
